May 24, 2007 (San Diego) — A recent study found that among patients in a psychiatric hospital, the atypical antipsychotic quetiapine (Seroquel, AstraZeneca), which is approved for schizophrenia and ...
Off-label prescribing is when a medication is prescribed for a purpose not approved by the FDA. Insurance might cover off-label prescriptions, but it depends on the specific plan and often requires a ...
Most migraine management is off-label, doctors say. Sept. 10, 2010 -- Migraine sufferers like Barbara Trupin, who endured the severe headaches weekly for almost 20 years, will often do anything to get ...
ABILENE, Texas — Ozempic, an injectable drug used to control high blood sugar, is a helpful tool for type 2 diabetics - but one of the side effects of the drug has caused viral interest beyond just ...
An off-label prescription drug has been shown to help some non-verbal children with autism discover the ability to speak. The drug, leucovorin, is a prescription vitamin that functions similarly to ...
A new study finds that off-label drug use is associated with higher rates of adverse drug events in adults. Off-label use of prescription drugs is known to be associated with adverse drug events (ADEs ...
One of the most alarming things about COVID-19 is that there are no FDA-approved drugs to fight it. Instead, doctors have turned to medications such as azithromycin, chloroquine, hydroxychloroquine, ...
It can be linked to other problems, too, such as type 2 diabetes, cardiovascular disease and infertility, and is known to have a knock-on effect on the self-esteem and mental health of the sufferer.
When Pfizer’s COVID-19 vaccine was approved in August, it was only approved for ages 16 and up as a two-dose series. But since fully-approved vaccines and medications can be used “off label,” many of ...
Although Topamax is not FDA approved for weight loss, doctors may prescribe the drug off-label. Studies show that people taking Topamax for 24 weeks lose about 4.5% to 6.5% of body weight. Topamax may ...
The hype around the off-label use of the immunosuppressant rapamycin to prevent aging and increase longevity could be unfounded. This is the warning of researchers who have critically explored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results